by The fme Team | Nov 9, 2022 | Enterprise Content Management, Life Sciences
With the focus of regulated information processes shifting toward structured data exchange, pharma companies are investing heavily in systems to help them capture, collate, analyze, and manage that data in smart and efficient ways. But in their keenness to digitally...
by The fme Team | Nov 4, 2022 | Content Migration, Enterprise Content Management
Since the Hyland Summit in Düsseldorf three weeks have already passed, but what are three weeks compared to three years… At fme AG we are happy that we had the opportunity to join the first Hyland Summit after three years and get to talk to clients, new contacts and...
by The fme Team | Sep 27, 2022 | Content Migration, Enterprise Content Management, Life Sciences
3 common pain points and how to avoid them. As I explored recently, digital transformation can surface a series of perplexing data challenges for most organizations, but particularly those operating in life sciences. Such has been the inertia in the sector previously...
by The fme Team | Jul 1, 2022 | Content Migration, Enterprise Content Management, Life Sciences
It’s a misconception that simply adopting a new technology platform will lead to optimized new business processes. Successful outcomes rely on the usability of the migrated data along with the future state business process. The journey to digital transformation is as...
by The fme Team | Jun 20, 2022 | Content Migration, Enterprise Content Management, Life Sciences
EU IDMP SPOR data preparations remain as critical as ever, and an effective system migration will depend entirely on the groundwork done now. Here’s a new action plan. After much frustration and panic following EMA’s latest IDMP curveball (around how data will be...
by The fme Team | Jun 3, 2022 | Content Migration, Enterprise Content Management, Life Sciences
For validated content used in submissions, even 95% extraction accuracy is too risky. For a whole host of strategic and business efficiency reasons, not to mention compliance drivers (including preparation for the EU’s implementation of IDMP), most pharmaceutical...
